Ardelyx (ARDX) Operating Income (2013 - 2026)
Ardelyx (ARDX) posted Operating Income of -$32.8 million for Q1 2026, down 743.13% on a QoQ basis from $5.1 million in Q4 2025, and up 9.78% year-over-year from -$29.9 million in Q1 2025.
Ardelyx (ARDX) Operating Income (2013 - 2026) Analysis & Trends
Ardelyx's Operating Income history runs 14 years deep, the most recent figure standing at -$32.8 million for Q1 2026.
- Quarterly Operating Income rose 9.78% year-over-year to -$32.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.4 million (up 5.55% YoY) and the FY2025 annual result came in at -$41.0 million, down 46.61% from the prior year.
- Operating Income was -$32.8 million for Q1 2026 at Ardelyx, down from $5.1 million in the prior quarter.
- Across five years, Operating Income topped out at $12.1 million in Q4 2022 and bottomed at -$36.3 million in Q1 2025.
- A 5-year average of -$13.5 million and a median of -$16.6 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income surged 134.43% — and 2023, when it sank 330.47%.
- Ardelyx's Operating Income stood at $12.1 million in 2022, then sank by 330.47% to -$28.0 million in 2023, then surged by 129.03% to $8.1 million in 2024, then sank by 37.24% to $5.1 million in 2025, then plunged by 743.13% to -$32.8 million in 2026.
- Business Quant data shows ARDX's Operating Income at -$32.8 million in Q1 2026, $5.1 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -32.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.79 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 4.67 Mn |
| Jun 30, 2025 | -14.40 Mn |
| Mar 31, 2025 | -36.35 Mn |
| Dec 31, 2024 | 8.13 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | -24.68 Mn |
| Dec 31, 2023 | -27.99 Mn |
| Sep 30, 2023 | 7.40 Mn |
| Jun 30, 2023 | -16.62 Mn |
| Mar 31, 2023 | -26.06 Mn |
| Dec 31, 2022 | 12.14 Mn |
| Sep 30, 2022 | -21.88 Mn |
| Jun 30, 2022 | -26.22 Mn |
| Mar 31, 2022 | -27.81 Mn |
| Dec 31, 2021 | -35.27 Mn |
| Sep 30, 2021 | -42.24 Mn |
| Jun 30, 2021 | -44.83 Mn |